Home/Specialty/Neurology/Computerized Behavioral Therapy Device For Substance Use Disorders/reSET-O™

PEAR THERAPEUTICS, INC. 1.1 reSET-O™

Company Name

PEAR THERAPEUTICS, INC.

Catalog Number

1.1

Description

reSET-O Mobile Application runs on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application.Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

Have questions, or need more information? Contact Us

Pricing
Summary

Price Not Available

Out of Stock

Interested in this product?
Contact us or login to add to your watchlist.

Related Items

PEAR THERAPEUTICS, INC. 1 reSET-O®

reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.

PEAR THERAPEUTICS, INC. 1 reSET-O®

reSET-O® is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

PEAR THERAPEUTICS, INC. 1 reSET-O® Demo Version (Mobile App, Android)

reSET-O® Mobile Application running on Android. reSET-O is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with opioid use disorder (OUD). The Demo Version provides demonstration access to various prescription versions of the reSET-O product and is not intended for patients.

PEAR THERAPEUTICS, INC. 1 reSET-O® Mobile App, iOS

reSET-O® Mobile Application running on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

Yellofin Elite Leg Holder Lift-Assist Stirrups w/ Cart

Key features of the Baxter Hillrom Yellofin stirrups typically include: Lithotomy Positioning: Provides reliable lithotomy positioning with a boot-like design for the lower legs, allowing secure support while minimizing nerve stress. Self-adjusting Boot: The boot is designed to automatically adjust to the patient's anatomy, reducing the risk of pressure injuries. Lift Assist Mechanism: It features an assist mechanism to make leg adjustments smoother and easier for medical personnel. Enhanced Safety: Some models include a secure locking system that prevents unintentional adjustments during surgery. Durability: Made from high-grade materials to ensure longevity and withstand repeated sterilization. This system is widely used in OR environments for its precision and ergonomic advantages for both patients and clinicians.

Toul Meditech AB Mobile Operio

Operio Mobile is a clean air zone unit, with an integrateddetachable instrument tray, to be used in the operatingzone, which produces a directed, non-turbulent ultracleanair flow to the surgical site during ophthalmic,orthopedic and neuro surgery and to the sterileinstruments used during surgery.

General & Plastic Surgery

DIGIRAD CORPORATION Mobile Cardius 1

O&M HALYARD, INC. 89791 Halyard

HYH,STERIL,SLV,-,-,100

General & Plastic Surgery

PEAR THERAPEUTICS, INC. 1.1 reSET-O™

reSET-O Mobile Application runs on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application.Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

PEAR THERAPEUTICS, INC. 1 reSET-O® Mobile App, Android

reSET-O® Mobile Application running on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

PEAR THERAPEUTICS, INC. 1 reSET-O®

reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.

PEAR THERAPEUTICS, INC. 1 reSET-O®

reSET-O® is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

PEAR THERAPEUTICS, INC. 1 reSET-O® Demo Version (Mobile App, Android)

reSET-O® Mobile Application running on Android. reSET-O is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with opioid use disorder (OUD). The Demo Version provides demonstration access to various prescription versions of the reSET-O product and is not intended for patients.

PEAR THERAPEUTICS, INC. 1 reSET-O® Mobile App, iOS

reSET-O® Mobile Application running on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

Yellofin Elite Leg Holder Lift-Assist Stirrups w/ Cart

Key features of the Baxter Hillrom Yellofin stirrups typically include: Lithotomy Positioning: Provides reliable lithotomy positioning with a boot-like design for the lower legs, allowing secure support while minimizing nerve stress. Self-adjusting Boot: The boot is designed to automatically adjust to the patient's anatomy, reducing the risk of pressure injuries. Lift Assist Mechanism: It features an assist mechanism to make leg adjustments smoother and easier for medical personnel. Enhanced Safety: Some models include a secure locking system that prevents unintentional adjustments during surgery. Durability: Made from high-grade materials to ensure longevity and withstand repeated sterilization. This system is widely used in OR environments for its precision and ergonomic advantages for both patients and clinicians.

PEAR THERAPEUTICS, INC. 1.1 reSET-O™

reSET-O Mobile Application runs on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application.Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

PEAR THERAPEUTICS, INC. 1 reSET-O® Mobile App, Android

reSET-O® Mobile Application running on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

PEAR THERAPEUTICS, INC. 1 reSET-O®

reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.

PEAR THERAPEUTICS, INC. 1 reSET-O®

reSET-O® is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

PEAR THERAPEUTICS, INC. 1 reSET-O® Demo Version (Mobile App, Android)

reSET-O® Mobile Application running on Android. reSET-O is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with opioid use disorder (OUD). The Demo Version provides demonstration access to various prescription versions of the reSET-O product and is not intended for patients.

PEAR THERAPEUTICS, INC. 1 reSET-O® Mobile App, iOS

reSET-O® Mobile Application running on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

Additional Details

Device Identifier

10851580008064

Is RX

Yes

Is Over the Counter

No

Requires Sterilization

No

Is Sterile

No

Is Single Use

No

Categories

Barcode Mapping

Unit of Measurement	Eaches	GTIN
Each	1	10851580008064